Diazepam Binding Inhibitor Rabbit Polyclonal Antibody (BF405)
Diazepam Binding Inhibitor Rabbit Polyclonal Antibody (BF405) is a BF405 conjugated antibody targeting DBI. This antibody is suitable for IF. It exhibits reactivity with Mouse samples.
Product Specifications
Product Name Alternative
ACBD; ACBD 1; ACBD1; ACBP; ACBP_HUMAN; Acyl CoA binding domain containing 1; Acyl CoA binding protein; Acyl Coenzyme A binding domain containing 1; acyl coenzyme A binding protein; Acyl-CoA-binding protein; acyl-Coenzyme A binding domain containing 1; CCK RP; CCKRP; Cholecystokinin releasing peptide trypsin sensitive; DBI; Diazepam-binding inhibitor; endozepine; EP; GABA receptor modulator acyl Coenzyme A binding protein; GABA receptor modulator.
Reactivity
Mouse
Immunogen
KLH conjugated synthetic peptide derived from human ACBD/Diazepam Binding Inhibitor (61-87/87aa)
Target
DBI
Clonality
Polyclonal
Conjugation
BF405
Field of Research
Pharmacology & Drug Discovery
Purification
Affinity purified by Protein A
Concentration
1mg/ml
Dilution
IF=1:100-500
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Prediction Reactivity
Bovine, Human, Porcine, Rat, Sheep
Tested Applications
IF
Host or Source
Rabbit
Preservative
0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882085-500 1x 500 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BR2000-SP 1 Each
Additional platform separators (4 ea.) . Adds 1.25" to platform separation
Sign In for Pricing
View Details 
